BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  OCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces Disability Progression Over Five Years in Relapsing and Primary Progressive Multiple Sclerosis

  People with relapsing MS (RMS) treated sooner with OCREVUS had earlier reduction in disease activity and less disability progression vs. those who switched from interferon beta-1α

  October 10, 2018

   · 

  14 min read
• Business

  TopAlliance and UTHealth Sign a Patent and Technology License Agreement

  Access Novel Antibody Technology

  October 10, 2018

   · 

  2 min read
• Business

  Collaboration Between National Physical Laboratory and Mediso

  AnyScan (SPECT/CT/PET) triple modality system

  October 10, 2018

   · 

  2 min read
• DelMar Announces Further Validation of the Mechanism of Action of VAL-083

  DelMar Pharmaceuticals, Inc. today announced the publication of a peer-reviewed scientific paper on the mechanism of action for VAL-083, the Company’s product candidate, in Cell Death and Disease by Nature Publishing Group.

  October 10, 2018

   · 

  5 min read
• Deals

  MedMen Acquires First Dispensary in San Francisco Bay Area

  Company Expands Footprint in its Home State into Northern California

  October 10, 2018

   · 

  6 min read
• Business

  Merck to Hold Third-Quarter 2018 Sales and Earnings Conference Call on October 25

  Merck will hold its third-quarter 2018 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Thursday, Oct. 25.

  October 10, 2018

   · 

  3 min read
• Policy

  Evogen’s Cognizance Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent for Its Diagnostic Biomarkers for Epilepsy

  New Patent Provides Further Protection for Neuro-Inflammatory Biomarkers for the Diagnosis of Epileptic Seizures

  October 10, 2018

   · 

  4 min read
• Pharm Country

  Gotham Therapeutics Launches with $54 Million Series A

  Versant-seeded company translating insights about RNA-modifying protein targets into drug candidates

  October 10, 2018

   · 

  7 min read
• Business

  Britta Fuenfstueck Appointed as New CEO of the HARTMANN GROUP

  Britta Fuenfstueck to succeed Andreas Joehle as CEO of the HARTMANN Group on January 1, 2019

  October 10, 2018

   · 

  4 min read
• Essity and the United Nations Foundation Lead Dialogue on UN’s Sustainable Development Goals

  Today, the hygiene and health company Essity will open the annual meeting of the United Nations Foundation’s dialogue on the UN’s sustainable development goals.

  October 10, 2018

   · 

  2 min read